MeSH D004392 - dwarfism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004700:Endocrine system diseases
0 Companies
0 Drugs
Success rate
D001848:Developmental bone diseases
0 Companies
0 Drugs
Success rate
D030342:Inborn genetic diseases
D004392:Â
Dwarfism
D003409:Congenital hypothyroidism
0 Companies
0 Drugs
Success rate
D004393:Pituitary dwarfism
D003057:Cockayne syndrome
0 Companies
0 Drugs
Success rate
D050336:Mulibrey nanism
0 Companies
0 Drugs
Success rate
D056846:Weill-marchesani syndrome
0 Companies
0 Drugs
Success rate
D056730:Silver-russell syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Sandoz | Somatropin | Omnitrope |  | 2006-04-12 |  |  |
| Eli Lilly | Somatropin | Humatrope |  | 1986-10-16 |  |  |
| Pharmacia & Upjohn | Somatropin | Genotropin |  | 1995-08-24 |  |  |
| Genentech | Somatropin | Nutropin |  | 1993-11-17 |  |  |
| Novo Nordisk | Somatropin | Norditropin |  | 2000-06-20 |  |  |
| Ferring Pharmaceuticals | Somatropin | Zomacton |  | 1995-05-25 |  |  |
| Ipsen | Somatropin | NutropinAq |  | 2001-02-15 |  |  |
| EMD Serono | Somatropin | Saizen |  | 1996-10-08 |  |  |
| Somatropin | Serostim |  | 1996-08-23 |  |  | |
| BioMarin Pharmaceutical | Vosoritide | Voxzogo | 2030-05-20 | 2021-11-19 | $672.332 M | Q4/23-Q3/24 |
| BioPartners | Somatropin | Somatropin Biopartners |  | 2013-08-05 |  |  |
| Somatropin | Valtropin |  | 2006-04-24 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
50%1/2
Phase 3
100%3/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use